Display Settings:

Format

Send to:

Choose Destination
    J Exp Med. 2006 Oct 30;203(11):2485-94. Epub 2006 Oct 9.

    IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

    Source

    Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD 20892, USA. mk512@york.ac.uk

    Abstract

    Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that is caused in part by a dysregulated immune response to the intestinal flora. The common interleukin (IL)-12/IL-23p40 subunit is thought to be critical for the pathogenesis of IBD. We have analyzed the role of IL-12 versus IL-23 in two models of Helicobacter hepaticus-triggered T cell-dependent colitis, one involving anti-IL-10R monoclonal antibody treatment of infected T cell-sufficient hosts, and the other involving CD4+ T cell transfer into infected Rag-/- recipients. Our data demonstrate that IL-23 and not IL-12 is essential for the development of maximal intestinal disease. Although IL-23 has been implicated in the differentiation of IL-17-producing CD4+ T cells that alone are sufficient to induce autoimmune tissue reactivity, our results instead support a model in which IL-23 drives both interferon gamma and IL-17 responses that together synergize to trigger severe intestinal inflammation.

    PMID:
    17030948
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2118119
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 1.
    Figure 3.
    Figure 5.
    Figure 2.
    Figure 4.
    Figure 6.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk